2,740
+13.93%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About HLB Therapeutics Co
Its shares trade on KOSDAQ under the ticker 115450.KQ. It has been listed since 26 March 2010. In the fiscal year to 31 December 2025, it reported revenue of ₩69.56bn and a net loss of ₩9.23bn. At that date it held total assets of ₩228.66bn and shareholders' equity of ₩150.25bn.
HLB Therapeutics Co., Ltd. engages in the development and sale of vaccines and manufacture of electronic parts. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2010-03-26. Along with its affiliates, the Company operates solution business segment, which provides embedded graphic user interface (GUI) software solutions as well as wired and wireless integration multimedia platform solutions. Its embedded GUI products include FXUI-two-dimensional (2D), FXUI-three-dimensional (3D) and FX Studio, which are used for cellular phones and embedded equipment. Its wired and wireless integration multimedia platform products include FX-Flash and others, which are used for cellular phones and other mobile devices; electronic components manufacturing business segment, which provides transformers, pumps, motors and others, as well as educational and bio pharmaceutical business segments.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 26 Mar 2010
- Website
- hlbtherapeutics.co.kr ↗
Leadership
Pay as last reported
- Yil ParkCo-Chief Executive Officer, Director, since 2013
- Won Seok YangCo-Chief Executive Officer, Director, since 2014
- Bon Ju GuInternal Auditor
- Byeong Gi KimAssistant Managing Director
- Sang Gi LeeAssistant Managing Director
- Mr. Hun Sik KimDirector
- Gyeong Bong RiDirector
- Jong Hyo YoonDirector
- Se Hui ParkNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company operates in the health care sector within the biotechnology industry.
- It has been publicly traded since its IPO in 2010.
- It is headquartered in Seongnam, South Korea.
Weaknesses
- The source description is explicitly treated as untrusted facts.
- The provided text contains conflicting business segments like vaccines and electronic parts.
- No specific financial data or performance metrics are available in the input.
Opportunities
- The company engages in the development and sale of vaccines.
- It manufactures electronic components such as transformers and motors.
- It provides embedded GUI software solutions for mobile devices.
Threats
- The source material is marked as untrusted and unreliable.
- The business description mixes unrelated sectors like biotechnology and electronics.
- Specific operational details are vague and potentially contradictory.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.